Investing.com - Merck reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.18 on revenue of €4.63B. Analysts polled by Investing.com anticipated EPS of €1.7 on revenue of €4.54B.
Merck shares are down 3% from the beginning of the year, still down 9.36% from its 52 week high of €150.10 set on April 19. They are under-performing the STOXX 600 which is up 9.89% from the start of the year.
Merck shares lost 1.82% in intra-day trade following the report.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Siemens AG on Friday, who reported EPS of €2.79 on revenue of €14.67B, compared to forecasts EPS of €1.85 on revenue of €14.16B.
Bayer had beat expectations on Wednesday with first quarter EPS of €2.59 on revenue of €12.33B, compared to forecast for EPS of €2.47 on revenue of €12B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar